Read about Endologix
in the news

Embrace the evidence.

The Latest:

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

See Release

All News


Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference

ELEVATE IDE Study highlights the Safety and Effectiveness of the ALTO® Abdominal Stent Graft System in One-year Results; Data to Be Presented at 2022 VEITHsymposium

Endologix Submits Premarket Approval (PMA) Application to FDA for the DETOUR™ System.

Endologix Receives CE Mark Certification under EU MDR for AFX®2 Endovascular AAA System

Endologix Reports 12 Month Data from DETOUR 2 Clinical Trial at 2022 Vascular Annual Meeting